Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma
Clinical trial NCT00180011 · COMPLETED
Trial details
- NCT number
- NCT00180011
- Sponsor
- DiMango, Emily, M.D.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2012-02-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.